drugset / Trial / NCT06849115
Effects of L-Carnitine in Amyotrophic Lateral Sclerosis Patients With CHCHD10 Mutations
NaSingle-groupOpen-labelTreatment
Summary
The study was designed as a single-center, open-label, single-arm pilot study to estimate the safety and efficacy L-carnitine in ALS patients with CHCHD10 mutations.
Timeline
- Start
- 2024-07-18
- Primary completion
- 2024-12-19
- Completion
- 2025-02-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-carnitine | Other / unclassified | 1000 mg | Intravenous |